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A B S T R A C T
Background: The diagnostic value of bronchoalveolar lavage in patients with negative sputum/smear for
tuberculous bacilli has been well studied. However, its value in the subset of patients with both negative
sputum/smear and culture is seldom reported.
Methods: A retrospective study of patients referred for diagnostic bronchoscopy for the suspicion of
pulmonary tuberculosis during the period from April 1st, 2015 to March 30th, 2016, and who had
negative sputum/smear and culture for tuberculous bacilli.
Results: One hundred and ninety patients fulfilled the inclusion criteria. Bronchoalveolar lavage detected
further 61/190 (32.1%) pulmonary tuberculosis cases. Bronchoalveolar lavage mycobacterial culture and
polymerase chain reaction (positive in 60/190 (31.6%) and 58/190 (30.5%) of patients respectively)
provided the highest diagnostic yield, whereas direct smear provided the lowest yield. Bronchoalveolar
lavage had a sensitivity of 89.7%, a specificity of 100%, a positive predictive value of 100%, a negative
predictive value of 94.6%, and a test accuracy of 96.3% in suspected pulmonary tuberculosis cases with
negative sputum/smear and culture. Positive bronchoalveolar lavage yield for tuberculosis was
significantly associated with a positive QuantiFERON-TB Gold In-Tube test, positive purified protein
derivative skin test, radiological evidence of upper zone abnormality and patient’s origin being from the
Indian subcontinent.
Conclusion: Bronchoalveolar lavage should be pursued as a useful diagnostic tool for suspected
pulmonary tuberculosis cases when sputum/smear and culture are negative. Its value is higher in the
subset of patients with positive QuantiFERON-TB Gold In-Tube test, positive purified protein derivative
skin test, upper zone abnormality on radiograph or being from the Indian subcontinent.
© 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Tuberculosis (TB) is among the top 10 causes of death
worldwide, and the leading cause from a single infectious agent.
In 2017, TB caused an estimated 1.3 million deaths among Human
Immunodeficiency Virus (HIV)-negative people, and an additional
300,000 deaths among HIV-positive people. About 10 million new
cases of TB were diagnosed during the same year (World Health
Organization, 2018). Infection with Mycobacterium tuberculosis
(MTB) is acquired by inhalation of bacilli-containing droplet nuclei
that are small enough (diameter 1–5 mm) to reach the alveoli (Longciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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of TB, accounting for about 85% and 70% of TB cases prior to and
after the emergence of HIV respectively (Farer et al., 1979; Small
et al., 1991). Early and prompt diagnosis of pulmonary TB is of
paramount importance for the prevention of disease progression,
spread to other contacts, and to avoid long-term sequelae. Direct
sputum smear microscopy is the most widely used method for
diagnosing pulmonary TB and is widely available in many
countries. Recent studies have shown that a good-quality
microscopy of two consecutive sputum specimens is able to
identify the vast majority (95%–98%) of smear-positive TB patients
(Davis et al., 2013; Ryu, 2015; World Health Organization, 2011).
Consequently, the World Health Organization (WHO) recommends
that only two sputum specimens are required and they may be
performed on the same day, providing that acid-fast bacilli (AFB)
microscopy is quality-assured. This can help to reduce the risk of
defaulting during the diagnostic process, as well as the indirect
costs of diagnosis to patients (World Health Organization, 2011).
Nevertheless, despite being a rapid, simple, and inexpensive tool
for diagnosing pulmonary TB, direct sputum microscopy has
significant limitations. These limitations include the low and
variable sensitivity (16–60%) and inability of some patients to
produce sputum (Ryu, 2015; Harries, 2004). MTB culture is
considered the gold-standard diagnostic test for TB. It has a
higher sensitivity than AFB smear with the ability to detect 1 102
bacilli per ml. Furthermore, MTB culture has the advantages of
distinguishing between non-tuberculous and tuberculous myco-
bacteria and ability to perform drug sensitivity testing. Neverthe-
less, the long time required for MTB culture and the significant
laboratory infrastructure it requires are its major drawbacks
(Harries, 2004; Cudahy and Shenoi, 2016). Previous studies have
confirmed the ability of patients with sputum/smear-negative
pulmonary TB to transmit the disease to other people. In fact,
smear-negative patients with pulmonary TB contributed signifi-
cantly to the incidence of the disease in different parts of the world
(Behr et al., 1999). The threshold for detecting bacilli on light
microscopy is about 5000–10,000 bacilli per ml, while the
infecting dose of MTB is estimated to be fewer than ten organisms
(Behr et al.,1999; Yeager et al.,1967; Hobby et al.,1973). TB remains
a common health problem in the State of Qatar with an incidence
of 40/100,000 population per year. About 97% of TB patients are
expatriates (mostly from Asian countries with high TB prevalence).
Qatar has a highly effective National TB Program with one National
TB Reference Laboratory that performs a full range of laboratory
diagnoses and a case detection rate exceeding 70%. All medications,
laboratory and radiological investigations for diagnosis of TB are
provided free-of-charge to all patients (Central Intelligence
Agency, 2019; Khattab et al., 2015; AL-Suwaidi, 2015; Ibrahim
et al., 2016). A number of previous studies have documented the
diagnostic value of bronchoalveolar lavage (BAL) in patients with
negative/sputum smear for AFB (Altaf Bachh et al., 2010; Quaiser
et al., 2012). However, to the best of our knowledge, BAL value in
patients with additional negative sputum/MTB culture has seldom
been reported. The primary objective of this study was to evaluate
the diagnostic yield of BAL in patients with suspected pulmonary
TB (based on radiologic and/or clinical background) and in whom
both sputum/direct AFB smear and MTB culture were negative.
Secondary objective was to study the association between BAL TB
yield in these patients and different patient and laboratory-related
characteristics.
Methods
This was a retrospective study of adult patients who were
referred to the Thoracic Center of Hamad General Hospital (HGH)
for a diagnostic bronchoscopy based on radiologic and/or clinicalsuspicion of pulmonary TB during the period from April 1st, 2015
till March 30th, 2016. Patients who had at least two samples of
sputum/AFB smear and MTB culture negative were included in the
study. Patients with negative sputum/AFB smear but positive
sputum/MTB culture, patients with positive sputum/AFB smear,
patients with suspected extra-pulmonary TB and patients who
were referred for bronchoscopy for reasons other than suspected
pulmonary TB were all excluded from the study. Both electronic
and non-electronic health records of the included patients were
extensively reviewed by at least two investigators. Data regarding
clinical and demographic characteristics, results of various
laboratory and radiologic tests and the treating physician’s final
diagnosis (based on various tests and response to treatment) were
recorded in a structured form.
Bronchoscopy and BAL technique at HGH
Bronchoscopy and BAL at HGH is performed according to the
American Thoracic Society (ATS) guidelines (Meyer et al., 2012),
using the Pentax flexible bronchoscope with minimal internal
diameter of 2.0 mm. Sedation/anesthesia is achieved by intrave-
nous Midazolam/Fentanyl with upper airway topical 10% Xylocaine
spray. BAL is performed prior to other planned procedures and
suction is avoided/minimized prior to BAL. Topical Lidocaine 2% is
used to minimize cough but limited as much as possible to avoid its
bacteriostatic effect. Bronchoscope is advanced till it is wedged in
the desired sub-segmental bronchus based on radiological
findings. Saline is infused in aliquots of 30 ml each followed by
a gentle suction to collect the specimen in a collection trap. Total
amount of saline used for infusion is 100– 300 ml with aim of
return of 10–30% infused volume. Samples are submitted for MTB
smear/culture and PCR and contain at least 10 ml volume of fluid.
Sputum collection and examination for suspected pulmonary TB at
HGH
Sputum for AFB is collected at HGH according to the National
Reference TB Laboratory, Hamad Medical Corporation (HMC)
guidelines and the international standards (Hamad Medical
Corporation, 2019; Lumb et al., 2019). Patients with suspected
pulmonary TB are required to collect two first morning sputum
samples on two separate days for AFB smear and MTB culture.
Patients are requested to rinse the mouth with tap water, breathe
deeply and cough several times to achieve a deep specimen (thick
mucoid sputum and not saliva). Patient should expectorate into a
dry, sterile and labeled container. The container is sealed tightly.
Sputum induction procedure performed by a trained nurse (using
hypertonic 3–5% saline nebulization) is used when a patient is not
able to provide sputum samples. The National Reference TB
Laboratory performs the following tests routinely on any sample of
a suspected TB case: Fluorescence microscopy, Ziehl-Neelsen (ZN)
staining technique, Polymerase Chain Reaction (PCR) (GeneXpert
MTB/RIF assay) and MTB culture (both solid and liquid media using
BACTEC MGIT 960 media).
Statistical analysis
Qualitative and quantitative data were expressed as frequency
with percentage and mean  SD with median and range. Descrip-
tive statistics were used to summarize demographic and all other
clinical characteristics of the participants. Associations between at
least 2 qualitative or categorical variables were assessed using χ2
test. For small cell frequencies, χ2 test with a continuity correction
factor or the Fisher exact test was applied. Pictorial presentations
of the key results were made using appropriate statistical graphs. A
2-sided P value less than .05 was considered statistically
Table 2
Main laboratory and radiologic findings.
N (%)
PPD skin test
(n = 129)
Positive 119 (92.2%)
Negative 10 (7.8%)
QFT
(n = 54)
Positive 28 (51.9%)
Negative 26 (48.1%)
Side of abnormality on chest radiograph
(n = 169)
Right side abnormality 86 (50.9%)
Left side abnormality 34 (20.1%)
Bilateral abnormality 49 (29.0%)
Lung zone involved on chest radiograph
(n = 190)
Upper zone 117 (61.6%)
Middle zone 11 (5.8%)
Lower zone 20 (10.5%)
More than one zone 42 (22.1%)
Main abnormality on chest radiograph
(n = 168)
Fibrosis 13 (7.7%)
Cavitation 23 (13.7%)
Infiltrates 114 (67.9%)
Mass 3 (1.8%)
Pleural thickening 1 (0.6%)
Pleural effusion 1 (0.6%)
Consolidation 9 (5.4%)
Miliary shadows 4 (2.4%)
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calculating sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) using the standard
formulae. Final treating physician’s diagnosis that was based on
results of different tests and response to treatment was considered
as the gold standard. (All decisions to treat as TB in the State of
Qatar are to be approved and monitored by the Communicable
Disease Center – CDC after a thorough review of all test results).
None of the primary treating physicians were involved in the study.
All statistical analyses were performed using SPSS 22.0 (SPSS, Inc.,
Chicago, Illinois).
Results
One hundred and ninety patients (all HIV-negative) fulfilled
the study inclusion criteria. Mean age was 33  10 years. Males
constituted 85.3% of patients. Majority of patients were expatri-
ates from the Indian subcontinent (77.4%), unskilled workers
(85.6%) and asymptomatic (89.5%) (Table 1). Purified Protein
Derivative (PPD) skin test was performed in 129 patients (positive
in 92.2% “defined as induration of 10 mm or more”) and
QuantiFERON-TB Gold In-Tube test (QFT) in 54 patients (positive
in 51.9%). All patients had abnormal chest radiographs with upper
zone abnormality noted in 117/190 (61.6%). The most common
abnormality on chest radiograph was pulmonary infiltrates
(67.9%) (Table 2). BAL detected 61/190 (32.1%) pulmonary TB
cases of the sputum/smear and culture-negative cases. Further-
more, BAL identified 2/190 (1.1%) malignancies, 4/190 (2.1%)
fungal infections and 6/190 (3.2%) bacterial infections as the
causes of abnormal chest radiographs. BAL/MTB culture and BAL/
TB PCR (positive in 60/190 (31.6%) and 58/190 (30.5%) of patients
respectively) provided the maximum diagnostic yield. BAL/direct
AFB smear was positive in only 2/190 (1.1%) of cases. Using theTable 1
Characteristics of the study population.
Age (years)
(n = 190)
Mean 33.3  10
Median 33
Gender
(n = 190)
Male 162 (85.3%)
Female 28 (14.7%)
Nationality
(n = 190)
Indian subcontinent 147 (77.4%)
Philippines 24 (12.6%)
Others 19 (10.0%)
Occupation
(n = 187)
Unskilled 160 (85.6%)
Semi-skilled 17 (9.1%)
Skilled 5 (2.7%)
Unemployed 5 (2.7%)
Smoking history
(n = 190)
Non-smokers 182 (95.8%)
Smokers 8 (4.2%)
Symptoms
(n = 190)
Asymptomatic 170 (89.5%)
Cough 11 (5.8%)
Fever 3 (1.6%)
Hemoptysis 6 (3.2%)final treating physician’s diagnosis as the gold-standard, BAL had
a sensitivity of 89.7%, a specificity of 100%, a positive predictive
value of 100%, a negative predictive value of 94.6%, and a test
accuracy of 96.3% for the diagnosis of pulmonary TB in sputum/
smear and culture-negative cases suspected of having the disease.
Positive BAL yield was significantly associated with a positive QFT,
positive PPD skin test, presence of upper zone abnormality on
chest radiograph and patient’s origin being from the Indian
subcontinent (Tables 3 and 4).Table 3
Yield and diagnostic utility of BAL.
Yield
(n = 190)
Negative yield 116 (61.1%)
Active pulmonary TB 61 (32.1%)
Malignancy 2 (1.1%)
Fungal infection 4 (2.1%)
Bacterial infection 6 (3.2%)
MOTT 1 (0.5%)
Positive BAL microbiologic tests
(n = 190)
Positive AFB smear 2 (1.1%)
Positive MTB complex PCR 58 (30.5%)
Positive MTB complex culture 60 (31.6%)
Diagnostic utility of BAL
(n = 190)
Sensitivity 89.7%
Specificity 100%
Positive predictive value 100%
Negative predictive value 94.6%
Accuracy 96.3%
Table 4
Association between BAL TB yield and different variables.
Variable Positive BAL TB yield
(N)
Negative BAL TB yield
(N)
P value
Nationality Indian subcontinent 43 104 0.045
Philippines 13 11
Others 5 14
Age (years) 20–40 49 93 0.356
41–60 10 33
>60 2 3
Occupation Unskilled 56 104 0.211
Semiskilled 2 15
Skilled 1 4
Unemployed 1 4
PPD Positive 48 71 0.011
Negative 0 10
QFT Positive 9 19 0.026
Negative 2 24
Presence of respiratory symptom Asymptomatic 57 113 0.220
Respiratory symptoms present 4 16
Abnormal side on chest radiograph Right side 31 55 0.611
Left side 10 24
Bilateral 14 35
Abnormal zone on chest radiograph Upper Zone 45 72 0.019
Mid Zone 2 9
Lower Zone 1 19
More than one zone 13 29
Main abnormality on chest radiograph Fibrosis 5 8 0.261
Cavitation 11 12
Infiltrates 38 76
Mass 0 3
Pleural thickening 0 1
Pleural effusion 0 1
Consolidation 1 8
Miliary seeds 0 4
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Subjects with untreated TB can infect up to 10 people over a
year. Sputum/smear-negative TB is a common clinical problem and
constitutes a diagnostic challenge to physicians. Besides being able
to infect other people, delayed diagnosis of smear-negative
pulmonary TB is a cause of significant mortality and morbidity
and can lead to irreversible lung damage (Lumb et al., 2019). Hence,
the Stop-TB-Strategy emphasizes the timely diagnosis and
treatment of all cases of TB, including smear-negative pulmonary
TB (Shah et al., 2012; WHO, 2007). Sputum/culture-negative TB is
another entity of pulmonary TB that is encountered in developed
and developing countries. In New York City, approximately 27% of
TB cases are reported to be culture-negative (Annual TB summary,
2013). In 2013, the Center for Disease Control (CDC) has reported a
23% culture-negative rate for TB cases in the United States (Centers
for Disease Control and Prevention, 2013–2015; Asghar et al.,
2018). Fiberoptic bronchoscopy is a relatively safe procedure. Since
its introduction in the 1960s, published rates of complication from
fiberoptic bronchoscopy have ranged from <0.1 to 11%, with
mortality generally reported between 0 and 0.1% (Stahl et al., 2015).
Among the many advantages of fiberoptic bronchoscopy in TB
diagnosis are visualizing endobronchial abnormalities and feasi-
bility for BAL, biopsy, and tissue sampling. The current study
confirmed the important value of BAL via fiberoptic bronchoscopy
in subjects with both sputum smear and MTB culture-negative
subjects with clinical suspicion of pulmonary TB. BAL could
identify 61/190 (32.1%) of those patients as pulmonary TB cases.
This finding is in agreement with findings from previous studies
that investigated the value of BAL/washings in sputum smear-
negative pulmonary TB cases. In 1982, Soe et al. performed a
fiberoptic bronchoscopy on 65 patients suspected of having active
pulmonary TB who were either sputum/smear-negative or had no
sputum to test. They reported a positive diagnostic yield of 38% inbronchial aspirate (So et al., 1982). Altaf Bachh et al. in a
prospective study of 75 suspected sputum/smear-negative pul-
monary TB cases found bronchial washings were the only
diagnostic method in 48.33% of cases (Altaf Bachh et al., 2010).
In a recent cross-sectional study, Krishnan et al. reported a
diagnostic yield of bronchial washings/AFB smear of 26.9% and
culture of 44.23% (Navaneedha Krishnan and Allwyn Vijay, 2017).
Higher yield of up to 86.6% was reported only occasionally
(Kalawat et al., 2010). A striking finding in the current study is the
very low yield of BAL/AFB smear in subjects with negative sputum/
AFB smear and MTB culture. To the best of our knowledge, this
finding was seldom reported in the literature. Previous studies that
demonstrated a significant yield of BAL/AFB smear included mainly
sputum/smear-negative but not sputum culture negative cases.
Our finding may question the role of BAL/AFB smear in the subset
of patients who demonstrated a negative sputum/MTB culture. The
yield of BAL in the current study was mainly derived from the MTB
culture and TB PCR, which emphasizes the importance of
performing these tests on BAL specimens when suspecting
pulmonary TB in patients with negative sputum/AFB smear and
MTB culture. Such diagnostic value of TB PCR and MTB culture in
sputum/smear-negative patients with clinical suspicion of pulmo-
nary TB have also been reported by other investigators (Tamura
et al., 2010). The current study has also demonstrated a higher
diagnostic utility (in terms of sensitivity, specificity, PPV and NPV)
of BAL in patients with negative sputum/AFB smear and MTB
culture compared to the few previous studies that addressed such
values. Nikbakhsh et al. reported BAL sensitivity, specificity, PPV
and NPV of 60%, 91%, 89% and 64% respectively (Nikbakhsh et al.,
2015). Nevertheless, the very high PPV observed in the current
study could be influenced by the prevalence of TB in the included
subjects. In the current study, we have shown that as many as 96%
of subjects whose BAL tests were negative for TB did not actually
have active pulmonary TB. An important finding in our study is the
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positive PPD skin test, presence of upper zone abnormality on
chest radiograph and patient’s origin being from the Indian
subcontinent. This finding emphasizes the importance of a vigilant
search for TB in patients with these clinical characteristics despite
being sputum/smear and culture-negative. Our study is among the
first to confirm the diagnostic value of BAL in the subset of patients
with both sputum/ AFB smear and MTB culture-negative pulmo-
nary TB. Furthermore, the relatively large number in the study
population adds more weight to the results. Besides the significant
yield of BAL in patients with sputum/AFB smear and MTB culture-
negative cases, we have also documented significant associations
between the positive BAL TB yield and different patients’ clinical
and laboratory characteristics as well as studied the diagnostic
utility of BAL in terms of sensitivity, specificity, negative and
positive predictive values. Such results were seldom reported in
previous studies (Nikbakhsh et al., 2015). Besides the limitations
inherent to retrospective studies, an important limitation of the
current study was the use of final treating physician’s diagnosis as
the gold standard to determine the sensitivity, specificity, PPV and
NPV of BAL. Nevertheless, based on an extensive review of the
medical records of patients included in this study, the physician’s
final diagnosis was based most of the time on objective parameters
such as other diagnostic tests or appropriate response to particular
therapies. Furthermore, the current study has included only
subjects referred for bronchoscopy for suspicion of pulmonary TB.
Subjects who were referred for reasons other than suspicion of
pulmonary TB were excluded. A selection bias, is therefore, could
have been created. A number of previous studies have documented
the role of post-bronchoscopy sputum collection in diagnosing
pulmonary TB in sputum/smear negative cases suspected of having
the disease (George et al., 2011). Unfortunately, post-bronchoscopy
sputum is not routinely collected for suspected TB cases in our
institution. Furthermore, the current study did not examine drug
sensitivity of the MTB detected in BAL specimens.
Conclusion
The current study suggests that BAL is a useful tool in
diagnosing pulmonary TB in the subset of patients with negative
sputum/AFB smear and MTB culture who are suspected of having
the disease. Positive BAL yield in this subset of patients is
significantly associated with a positive QFT, a positive PPD skin test,
presence of upper zone abnormality on chest radiograph and
patient’s origin being from the Indian subcontinent. Patients with
these clinical features should be a particular target of BAL
evaluation when sputum studies prove to be negative.
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